Full Text PA-95-007 SMALL GRANT PROGRAM FOR THE NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS NIH GUIDE, Volume 23, Number 40, November 18, 1994 PA NUMBER: PA-95-007 P.T. 34 Keywords: Communicative Disorders, Hearing Communicative Disorders, Speech Hearing 0775017 National Institute on Deafness and Other Communications Disorders PURPOSE This program announcement supersedes previous announcements of the National Institute on Deafness and Other Communication Disorders (NIDCD) Small Grant Program. This current Small Grant (R03) Program provides support for pilot research that is likely to lead to a subsequent individual research project grant (R01) or a First Independent Research Support and Transition (FIRST) (R29) award application. The research must be focused on areas within the mission of the NIDCD, that is, hearing, balance/vestibular, smell, taste, voice, speech, or language. HEALTHY PEOPLE 2000 The Public Health Service (PHS) is committed to achieving the health promotion and disease prevention objectives of "Healthy People 2000," a PHS-led national activity for setting priority areas. This program announcement, Small Grant Program for the NIDCD, is related to the priority area of clinical prevention services. Potential applicants may obtain a copy of "Healthy People 2000" (Full Report: Stock No. 017-001-11474-0) or "Healthy People 2000" (Summary Report: Stock No. 017-001-11473-1) through the Superintendent of Documents, Government Printing Office, Washington, DC 20402-9325 (telephone 202-783-3238). ELIGIBILITY REQUIREMENTS Applications may be submitted by domestic for-profit and non-profit organizations, public and private, such as universities, colleges, hospitals, laboratories, units of State and local governments, and eligible agencies of the Federal government. Racial/ethnic minority individuals, women, and persons with disabilities are encouraged to apply as principal investigators. Foreign organizations and institutions are not eligible. Current and previous recipients of NIH research grants such as small grant (R03) research projects grants (R01), or FIRST (R29) awards are ineligible for this small grant program, as are Principal Investigators of research subprojects of P01/P50/P60 grants. Individuals who have received research support from the National Science Foundation (NSF) are considered ineligible. Recipients of NIH Academic Research Enhancement Awards (R15) or Clinical Investigator Development Awards (K08) are eligible for this small grant program. Participation in the program by investigators at minority institutions is strongly encouraged. Small grant funds may not be used to support thesis or dissertation research. MECHANISM OF SUPPORT Applicants may request up to $25,000 (direct costs) per year through the small grant (R03) mechanism. The grant may not exceed two years and is not renewable. Before completion of the R03, investigators are encouraged to seek continuing support for research through a research project grant (R01) or FIRST (R29) award. RESEARCH OBJECTIVES The Small Grant program is designed to support basic and clinical scientists who are at the beginning stages of their independent research careers. INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN SUBJECTS It is the policy of the NIH that women and members of minority groups and their subpopulations must be included in all NIH supported biomedical and behavioral research projects involving human subjects, unless a clear and compelling rationale and justification are provided that inclusion is inappropriate with respect to the health of the subjects of the purpose of the research. This new policy results from the NIH Revitalization Act of 1993 (Section 492B of Public Law 103-43) and supersedes and strengthens the previous policies (Concerning the Inclusion of Women in Study Populations, and Concerning the Inclusion of Minorities in Study Populations) which have been in effect since 1990. The new policy contains some provisions that are substantially different from the 1990 policies. All investigators proposing research involving human subjects should read the "NIH Guidelines for Inclusion of Women and Minorities as Subjects in Clinical Research", which have been published in the Federal Register of March 28, 1994 (FR 59 14508-14513) and reprinted in the NIH Guide for Grants and Contracts, Volume 23, Number 11, March 18, 1994. Investigators also may obtain copies of the policy from the program staff listed under INQUIRIES. Program staff may also provide additional relevant information concerning the policy. APPLICATION PROCEDURES The submission, review, and award schedule for the Small Grant Program for FY 95 (these dates likely will differ for FY 96) is: Application Receipt Dates for FY95: 12/21/94 04/11/95 08/18/95 Institute Committee Review: Feb-Mar Jun-Jul Oct-Nov Council Review: May Oct Jan Earliest Funding: Jul Dec Apr Only one Small Grant application may be submitted by a principal investigator per receipt date. Applicants may not submit R01 or R29 applications on the same topic concurrently (to be considered at the same National Advisory Council cycle) with the submission of a Small Grant application. Applications are to be submitted on the grant application form PHS 398 (rev. 9/91) and prepared according to the directions in the application packet, with the exceptions noted below. Application kits are available at most institutional offices of sponsored research and may be obtained from the Office of Grants Information, Division of Research Grants, National Institutes of Health, Westwood Building, Room 449, Bethesda, MD 20892, telephone 301-710-0267. On the face page of the application: Item 2a Type "Small Grant Program NIDCD". Check the "YES" box. Sections 1-4: Do not exceed a total of five pages for the following sections: specific aims, background and significance, progress report/preliminary studies, and experimental design and methods. Tables and figures are included in the five page limitation. For revised applications, an additional introduction not to exceed one- half page is allowed. This introduction should respond to the comments and concerns of the Initial Review Group delineated in the summary statement. Applications that exceed the page limitation or NIH requirements for type size and margins (Refer to PHS 398 application for details) will be returned to the investigator. The five page limitation does not include Sections 5-9 (Human Subjects, Consortia, Literature cited). Appendix materials generally are not allowed. Use the mailing label in the application kit to mail the original and four copies of the application to: Division of Research Grants National Institutes of Health Westwood Building, Room 240 Bethesda, MD 20892** To ensure that the application is received in sufficient time for the review, send one copy of the application to: Acting Chief, Scientific Review Branch National Institute on Deafness and Other Communication Disorders Executive Plaza South, Room 400-C 6120 Executive Boulevard MSC 7180 Bethesda, MD 20892-7180 REVIEW CONSIDERATIONS A review committee of the NIDCD will evaluate each Small Grant application in accordance with the usual NIH peer review procedures and criteria. Applications will be evaluated with respect to the following criteria: o Scientific, technical, or clinical significance and originality of the proposed research. o Appropriateness and adequacy of the experimental approach and methodology proposed to carry out the research. o Appropriateness of the statistical methods proposed to analyze the results. o Potential of the proposed studies to lead to more extensive research. o Qualifications and research experience of the principal investigator. o Availability of resources necessary for the research, including any needed to supplement the budget. o Appropriateness of the proposed budget and timetable in relation to the scope of the proposed research. o The adequacy of the proposed means for protecting against or minimizing potential adverse effects upon humans, animals, or the environment. o Adequacy of adherence to guidelines for including gender and minority representation in any study population. Applications subsequently will be reviewed by the National Deafness and Other Communication Disorders Advisory Council. AWARD CRITERIA The award of grants is contingent on the (1) receipt of applications of high scientific merit; (2) responsiveness to this program announcement, including the eligibility of investigators; (3) relevance to the mission of NIDCD; and (4) the availability of appropriated funds. INQUIRIES Inquiries are encouraged. The opportunity to clarify any issues or questions from potential applicants is welcome Direct inquiries regarding programmatic issues to: Hearing Dr. Kenneth Gruber Telephone: (301) 402-3458\ Email: GruberK%NIDCD-EPS%NIH@fedtcp.ninds.nih.gov Balance/Vestibular Dr. Daniel Sklare Telephone: (301) 496-1804 Email: SklareD%NIDCD-EPS%NIH@fedtcp.ninds.nih.gov Smell/Taste Dr. Jack Pearl Telephone: (301) 402-3464 Email: PearlJ%NIDCD-EPS%NIH@fedtcp.ninds.nih.gov Smell/Taste Dr. Rochelle Small Telephone: (301) 402-3464 Email: SmallR%NIDCD-EPS%NIH@fedtcp.ninds.nih.gov Voice/Speech Dr. Beth Ansel Telephone: (301) 402-3461 Email: AnselB%NIDCD-EPS%NIH@fedtcp.ninds.nih.gov Language Dr. Judith Cooper Telephone: (301) 496-5061 Email: CooperJ%NIDCD-EPS%NIH@fedtcp.ninds.nih.gov The address and FAX number for all the above is: Division of Communication Sciences and Disorders National Institute on Deafness and Other Communication Disorders Executive Plaza South, Room 400-C 6120 Executive Boulevard MSC 7180 Bethesda, MD 20892 FAX: (301)402-6251 Direct inquiries regarding fiscal matters to: Sharon Hunt Grants Management Office National Institute on Deafness and Other Communication Disorders Executive Plaza South, Room 400-B 6120 Executive Boulevard MSC 7180 Bethesda, MD 20892-7180 Telephone: (301) 402-0909 AUTHORITY AND REGULATIONS This program is described in the Catalog of Federal Domestic Assistance No. 93.173. Awards are made under authorization of the Public Health Service Act, Title IV, Part A (Public Law 78-410), as amended by Public Law 99-158, 42 USC 241 and 285) and administered under PHS grants policies and Federal Regulations 42 CFR 52 and 45 CFR Part 74. This program is not subject to the intergovernmental review requirements of Executive Order 12372 or Health Systems Agency review. The Public Health Service (PHS) strongly encourages all grant recipients to provide a smoke-free workplace and promote the non-use of all tobacco products. This is consistent with the PHS mission to protect and advance the physical and mental health of the American people. .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |